Dissolved and financials
CVR: 42613207
DKK 1,762,455
Gross profit
Net result: DKK -12,890,414
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 30 June 2026
CVR · view overview
1 employee
CVR · 2025
Director role ended: Kenneth Berg
CVR · 30/06/2026
View the full event history
HEI Therapeutics ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company has been dissolved on 30 June 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2025). In 2024, the company reported a gross profit of DKK 1,762,455 and a net result of DKK -12,890,414 compared with DKK -381,736 the year before. Equity in the 2024 report amounted to DKK -13,516,567.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | 1.8M | -12.9M | 2.4M | -13.5M | 5 | |
| 202301/01/2023 – 31/12/2023 | 3.9M | -382K | 21M | -626K | 5 |
Compared to 1.036 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. HEI Therapeutics ApS is registered in the Danish CVR register with the status Dissolved and ceased on 30 June 2026.
The CVR number of HEI Therapeutics ApS is 42613207.
In 2024, HEI Therapeutics ApS reported a gross profit of DKK 1,762,455.
HEI Therapeutics ApS had 1 employee in 2025 according to the Danish CVR register.
HEI Therapeutics ApS was founded on 20 August 2021.
HEI Therapeutics ApS was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
As of June 30, 2026, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of HEI Therapeutics ApS.
As of June 30, 2026, Kenneth Berg has stepped down as liquidator of HEI Therapeutics ApS.
On June 30, 2026, HEI Therapeutics ApS exited liquidation.
HEI Therapeutics ApS was dissolved on June 30, 2026.
As of October 17, 2025, Winnie Edith Svendsen has left the board of directors of HEI Therapeutics ApS.
As of October 17, 2025, Kenneth Berg is registered as liquidator of HEI Therapeutics ApS.
As of October 17, 2025, Winnie Edith Svendsen has stepped down as director of HEI Therapeutics ApS.
As of October 17, 2025, Dan Taksony Solyom Høgdall has stepped down as director of HEI Therapeutics ApS.
As of October 17, 2025, Jesper Kimer has stepped down as director of HEI Therapeutics ApS.
As of October 17, 2025, Jesper Kimer has stepped down as chairman of HEI Therapeutics ApS.
On October 17, 2025, HEI Therapeutics ApS entered liquidation.
HEI Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK 1,762,455, and the net result was DKK -12,890,414.
HEI Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK 3,935,885, and the net result was DKK -381,736.
HEI Therapeutics ApS has published its interim report for the period August 20, 2021 to December 31, 2022.
As of September 21, 2022, Winnie Edith Svendsen has joined the board of directors of HEI Therapeutics ApS.
As of September 21, 2022, Winnie Edith Svendsen is registered as director of HEI Therapeutics ApS.
As of September 21, 2022, Dan Taksony Solyom Høgdall is registered as director of HEI Therapeutics ApS.
As of September 21, 2022, Jesper Kimer is registered as chairman of HEI Therapeutics ApS.
As of August 20, 2021, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of HEI Therapeutics ApS.
As of August 20, 2021, Jesper Kimer is registered as director of HEI Therapeutics ApS.
HEI Therapeutics ApS was founded on August 20, 2021.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at drive virksomhed med handel og produktion samt hermed beslægtet virksomhed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074
CVR 46543912
